Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Acta Haematol

Retrieve available abstracts of 90 articles:
HTML format

Single Articles

    June 2021
  1. CRISTIANO G, Nanni J, Sartor C, Parisi S, et al
    Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
    Acta Haematol. 2021 Jun 15:1-5. doi: 10.1159/000516003.
    PubMed     Abstract available

  2. DANYLESKO I, Canaani J, Shimoni A, Fein J, et al
    Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2021 Jun 8:1-7. doi: 10.1159/000515902.
    PubMed     Abstract available

    April 2021
  3. ZHANG X, Liu H, Zheng C, Tang B, et al
    Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
    Acta Haematol. 2021 Apr 13:1-11. doi: 10.1159/000507973.
    PubMed     Abstract available

    March 2021
  4. AITKEN MJL, Benton CB, Issa GC, Sasaki K, et al
    Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.
    Acta Haematol. 2021 Mar 18:1-6. doi: 10.1159/000513925.
    PubMed     Abstract available

    February 2021
  5. LANGERBEINS P, Eichhorst B
    Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
    Acta Haematol. 2021 Feb 25:1-11. doi: 10.1159/000514071.
    PubMed     Abstract available

  6. WU B, Mao ZJ, Wang Z, Wu P, et al
    Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine.
    Acta Haematol. 2021 Feb 24:1-8. doi: 10.1159/000513696.
    PubMed     Abstract available

    December 2020
  7. HERBORG LL, Nederby L, Brondum RF, Hansen M, et al
    Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.
    Acta Haematol. 2020 Dec 3:1-10. doi: 10.1159/000510504.
    PubMed     Abstract available

    November 2020
  8. SMOLEWSKI P, Robak T
    Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs.
    Acta Haematol. 2020 Nov 25:1-15. doi: 10.1159/000510768.
    PubMed     Abstract available

  9. SAMRA B, Kantarjian HM, Sasaki K, Alotaibi AS, et al
    Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant.
    Acta Haematol. 2020 Nov 25:1-8. doi: 10.1159/000510112.
    PubMed     Abstract available

    Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy.
    Acta Haematol. 2020 Nov 20:1-9. doi: 10.1159/000510980.
    PubMed     Abstract available

    August 2020
  11. PATEL SA, Bledsoe JR, Gordon J, Cerny J, et al
    Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche.
    Acta Haematol. 2020 Aug 19:1-5. doi: 10.1159/000508526.
    PubMed     Abstract available

    June 2020
  12. OLSON AL, Saliba RM, Oran B, Chen J, et al
    Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
    Acta Haematol. 2020 Jun 30:1-8. doi: 10.1159/000507012.
    PubMed     Abstract available

  13. ALHUMAID MS, Dasouki MJ, Ahmed SO, AbalKhail H, et al
    Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
    Acta Haematol. 2020 Jun 15:1-11. doi: 10.1159/000505715.
    PubMed     Abstract available

    May 2020
  14. ALANAZI W, Chen S, Lipton JH, Kim DD, et al
    Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Acta Haematol. 2020 May 19:1-8. doi: 10.1159/000507536.
    PubMed     Abstract available

    T-Cell Prolymphocytic Leukemia: Long-Term Remissions Challenging!
    Acta Haematol. 2020 May 11:1-2. doi: 10.1159/000507469.

  16. PAUL S, Rausch CR, Jain N, Kadia T, et al
    Treating Leukemia in the Time of COVID-19.
    Acta Haematol. 2020 May 11:1-13. doi: 10.1159/000508199.
    PubMed     Abstract available

  17. WAHNSCHAFFE L, Herling M
    What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 May 5:1-3. doi: 10.1159/000507415.

    April 2020
  18. POH C, Arora M, Ghuman S, Tuscano J, et al
    Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
    Acta Haematol. 2020 Apr 29:1-5. doi: 10.1159/000506918.
    PubMed     Abstract available

  19. SHUMILOV E, Hasenkamp J, Szuszies CJ, Koch R, et al
    Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 Apr 7:1-6. doi: 10.1159/000506302.
    PubMed     Abstract available

    March 2020
  20. TIMEUS F
    Noonan Syndrome and Acute Myeloid Leukemia in Adults: The Importance of a Correct Multidisciplinary Approach during Childhood.
    Acta Haematol. 2020 Mar 10:1-2. doi: 10.1159/000506388.

    January 2020
  21. BERNARDI S, Malagola M, Polverelli N, Russo D, et al
    Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?
    Acta Haematol. 2020 Jan 9:1-2. doi: 10.1159/000505088.

  22. RAANANI P, Sharf G
    Interview with a Patients' Advocate.
    Acta Haematol. 2020;143:1-4.

  23. KUAN JW, Su AT, Leong CF, Osato M, et al
    Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene.
    Acta Haematol. 2020;143:96-111.
    PubMed     Abstract available

  24. BANKAR A, Lipton JH
    Tyrosine Kinase Inhibitors in the Clinical Setting: A Conundrum of Choices.
    Acta Haematol. 2020;143:191-193.

  25. MAITI A, Franquiz MJ, Ravandi F, Cortes JE, et al
    Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
    Acta Haematol. 2020;143:567-573.
    PubMed     Abstract available

    December 2019
  26. AMITAI I, Lipton JH
    Avoiding the Thorns of the Gifted Red Rose: Case Report of Late Diagnosis of Polycythemia Rubra Vera in a Sibling Bone Marrow Transplantation Donor for a Patient with Chronic Myeloid Leukemia.
    Acta Haematol. 2019 Dec 18:1-2. doi: 10.1159/000504740.

    November 2019
    FLAG and Etoposide as Salvage Treatment in Acute Myeloid Leukemia.
    Acta Haematol. 2019 Nov 21:1-2. doi: 10.1159/000504379.

    October 2019
  28. WESTHUS J, Noppeney R, Schmitz C, Flasshove M, et al
    Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia.
    Acta Haematol. 2019 Oct 25:1-8. doi: 10.1159/000503056.
    PubMed     Abstract available

  29. PAROVICHNIKOVA E, Troitskaya V, Sokolov A, Gavrilina O, et al
    Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
    Acta Haematol. 2019 Oct 9:1-9. doi: 10.1159/000502435.
    PubMed     Abstract available

  30. SAUSSELE S, Haverkamp W, Lang F, Koschmieder S, et al
    Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
    Acta Haematol. 2019 Oct 7:1-15. doi: 10.1159/000501927.
    PubMed     Abstract available

    September 2019
  31. PAN P, Wang L, Wang Y, Shen L, et al
    Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia.
    Acta Haematol. 2019 Sep 12:1-13. doi: 10.1159/000501537.
    PubMed     Abstract available

    August 2019
  32. JIANG H, Li C, Liu Z
    Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Aug 21:1-9. doi: 10.1159/000500822.
    PubMed     Abstract available

    July 2019
  33. KEMPIN S, Sun Z, Kay NE, Paietta EM, et al
    Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
    Acta Haematol. 2019 Jul 23:1-9. doi: 10.1159/000500164.
    PubMed     Abstract available

    Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
    Acta Haematol. 2019 Jul 17:1-2. doi: 10.1159/000501330.

  35. SHIMONY S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, et al
    Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.
    Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975.
    PubMed     Abstract available

  36. LI Y, You MJ, Yang Y, Hu D, et al
    The Role of Tumor-Associated Macrophages in Leukemia.
    Acta Haematol. 2019 Jul 9:1-6. doi: 10.1159/000500315.
    PubMed     Abstract available

  37. SCHALLER T, Herold N
    Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia.
    Acta Haematol. 2019 Jul 8:1-2. doi: 10.1159/000501148.

    June 2019
  38. GUO Z, Chen Z, Xu Y, Zhang Y, et al
    The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Jun 18:1-7. doi: 10.1159/000500588.
    PubMed     Abstract available

  39. ZHANG Y, Gu H, Chen Q, Zhang Y, et al
    Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2019 Jun 5:1-10. doi: 10.1159/000500230.
    PubMed     Abstract available

    May 2019
  40. SANTOPIETRO M, Miano M, Palumbo G, Zhang K, et al
    Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
    Acta Haematol. 2019 May 21:1-2. doi: 10.1159/000497137.

    Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data.
    Acta Haematol. 2019 May 21:1-3. doi: 10.1159/000496449.

  42. ZENG Z, Liu W, Benton CB, Konoplev S, et al
    Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2019 May 21:1-9. doi: 10.1159/000495456.
    PubMed     Abstract available

    April 2019
  43. FELD J, Arnason J, O Apos Brien K, Nahas M, et al
    Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Acta Haematol. 2019;141:222-224.

    February 2019
  44. LI Z, Liu Y, Wang Q, Chen L, et al
    Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.
    Acta Haematol. 2019;141:164-175.
    PubMed     Abstract available

  45. TAHARA K, Koiso H, Osaki YH, Sekigami T, et al
    Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappaB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2019;141:135-137.

    January 2019
  46. BIELORAI B, Leitner M, Goldstein G, Mehrian-Shai R, et al
    Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Acta Haematol. 2019;141:119-127.
    PubMed     Abstract available

  47. EL CHAER F, Holtzman NG, Sausville EA, Law JY, et al
    Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
    Acta Haematol. 2019;141:107-110.
    PubMed     Abstract available

  48. SCHNEIDEWIND L, Neumann T, Zimmermann K, Weigel M, et al
    Is BK Virus-Associated Cystitis a Generalized Epithelial Disease?
    Acta Haematol. 2019;141:65-67.
    PubMed     Abstract available

    Factors Involved in the Selection of Treatment in Patients with Hematological Malignancies.
    Acta Haematol. 2019;141:54.

  50. SHARGIAN-ALON L, Raanani P, Rozovski U, Siegal T, et al
    Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Acta Haematol. 2019;141:19-22.
    PubMed     Abstract available

  51. BAIN BJ, Bene MC
    Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia.
    Acta Haematol. 2019;141:232-244.
    PubMed     Abstract available

  52. MULLER-THOMAS C, Tuchler H, Rudelius M, Schneider H, et al
    Serum Vitamin D Levels in Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Analysis.
    Acta Haematol. 2019;141:225-231.
    PubMed     Abstract available

  53. TIRRO E, Stella S, Massimino M, Zammit V, et al
    Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case Report.
    Acta Haematol. 2019;141:261-267.
    PubMed     Abstract available

  54. MO HY, Kim MS, Chung NG, Yoo NJ, et al
    Promoter Mutation Analysis of LEPROTL1 Gene in Acute Leukemias and Solid Tumors.
    Acta Haematol. 2019;141:214-215.

  55. TAN J, Xue M, Pan J, Cen J, et al
    Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients.
    Acta Haematol. 2019;142:79-86.
    PubMed     Abstract available

  56. SUCH E, Liquori A, Mora E, Marco-Ayala J, et al
    RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib.
    Acta Haematol. 2019;142:92-97.
    PubMed     Abstract available

  57. CAO Y, Yao L, Liu Y, Gu Q, et al
    An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3.
    Acta Haematol. 2019;142:98-104.
    PubMed     Abstract available

  58. DEVOS T, Verhoef G, Steel E, Mazure D, et al
    Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
    Acta Haematol. 2019;142:197-207.
    PubMed     Abstract available

    December 2018
  59. WANG L, Xu J, Tian X, Lv T, et al
    Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Acta Haematol. 2018;141:43-53.
    PubMed     Abstract available

    November 2018
  60. ABRUZZESE E, Trawinska MM, Neri B, Bondanini F, et al
    Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
    Acta Haematol. 2018;140:231-233.

    October 2018
  61. CHOTSAMPANCHAROEN T, Sripornsawan P, Duangchu S, Wongchanchailert M, et al
    Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children.
    Acta Haematol. 2018;140:203-208.
    PubMed     Abstract available

  62. NACHMIAS B, Shaulov A, Gatt ME, Shapira M, et al
    A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
    Acta Haematol. 2018;140:209-214.
    PubMed     Abstract available

  63. JIANG L, Deng T, Wang D, Xiao Y, et al
    Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:183-192.
    PubMed     Abstract available

    September 2018
  64. GIONA F, Santopietro M, Menna G, Putti MC, et al
    Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
    Acta Haematol. 2018;140:105-111.
    PubMed     Abstract available

  65. NAESENS L, Devos H, Nollet F, Michaux L, et al
    Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Acta Haematol. 2018;140:97-104.
    PubMed     Abstract available

  66. HA M, Kim JY, Han ME, Kim GH, et al
    TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:71-76.
    PubMed     Abstract available

    August 2018
  67. ROZOVSKI U, Keating MJ, Estrov Z
    Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
    Acta Haematol. 2018;140:51-54.
    PubMed     Abstract available

  68. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
    A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:30-39.
    PubMed     Abstract available

    June 2018
  69. PARK HS, Kim DY, Choi EJ, Lee JH, et al
    Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Acta Haematol. 2018;139:220-227.
    PubMed     Abstract available

    March 2018
  70. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.

    February 2018
  71. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Abstract available

    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.

  73. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Abstract available

  74. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Abstract available

    January 2018
  75. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.

  76. LV H, Hu S, Lu J, Zhai Q, et al
    Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Acta Haematol. 2018;139:176-182.
    PubMed     Abstract available

    September 2017
  77. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.

  78. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.

  79. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.

    July 2017
  80. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Abstract available

  81. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Abstract available

  82. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.

    June 2017
  83. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Abstract available

    May 2017
  84. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.

    April 2017
  85. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Abstract available

  86. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.

  87. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Abstract available

    January 2017
  88. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Abstract available

  89. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Abstract available

  90. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.